Crack Open the Champagne, AiCuris’ Antiviral Launched in Germany
Update (23/02/2018): Merck Sharp & Dohme (MSD), licensee of AiCuris, has launched letermovir in Germany under…
February 23, 2018 - 3 minutes
AiCuris
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread…
December 18, 2017 - 9 minutes
World Antibiotic Awareness Week: Here are Biotech’s Top 5 Strategies to Overcome Resistance
This week marks the WHO's World Antibiotic Awareness Week. We had a look at some of…
November 13, 2017 - 3 minutes
Potential Herpes Cure from Germany Fast-Tracked for Patients with Weak Immune Systems
AiCuris' Pritelivir has now secured FDA endorsement in the form of a Fast Track Designation…
August 1, 2017 - 2 minutes
Rise of the Superbugs: How is Biotech Fighting Antibiotic Resistance?
Fewer antibiotics are produced as development costs rise. We reached out to a few companies…
May 9, 2017 - 8 minutes
This Herpes Cure is Proving to Work Better than its Predecessors
AiCuris' candidate pritelivir has shown to perform better than current standard antiviral treatments against genital…
January 17, 2017 - 2 minutes
Cold Sore Cure Company enters the Antibiotic Resistance fight
AiCuris is developing a new antibiotic that might bring hope for patients in which all…
January 4, 2017 - 2 minutes
German Record-deal Antiviral drug Succeeds in Phase III
AiCuris' Letermovir succeeds in Phase III after being licensed to MSD in a record €442.5M deal. It acts on a…
October 20, 2016 - 2 minutes
Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure
Update (09/05/2017): AiCuris has started a Phase II trial, PRIOH-1, with the oral version of…
May 9, 2016 - 2 minutes
Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO
AiCuris is a Biotech company based on the Bayer Life Sciences park in Wuppertal (Germany).…
February 15, 2016 - 4 minutes
